
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $208.9M | $340.4M | $408.5M | $334.5M | $345.1M | |
Revenue Growth (YoY) | -31.32% | 62.94% | 20.01% | -18.12% | 3.16% | |
Cost of Revenues | $156.1M | $221M | $257.2M | $242.1M | $241.1M | |
Gross Profit | $52.8M | $119.4M | $151.4M | $92.4M | $103.9M | |
Gross Profit Margin | 25.27% | 35.07% | 37.06% | 27.63% | 30.12% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $55.6M | $77.5M | $96.3M | $103.2M | $94.2M | |
Other Inc / (Exp) | $1.5M | -$7.9M | $1.7M | $2.9M | $3.8M | |
Operating Expenses | $42.9M | $62.7M | $96.3M | $103.2M | $94.2M | |
Operating Income | $9.8M | $56.7M | $55M | -$10.8M | $9.7M | |
Net Interest Expenses | $1.6M | $980K | -- | -- | $5.7M | |
EBT. Incl. Unusual Items | $9.7M | $47.8M | $57.9M | -$7.7M | $7.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.7M | $11.7M | $14M | -$2.1M | $2M | |
Net Income to Company | $8.1M | $36.1M | $43.9M | -$5.6M | $5.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.1M | $36.1M | $43.9M | -$5.6M | $5.9M | |
Basic EPS (Cont. Ops) | $7.85 | $0.84 | $0.85 | -$0.11 | $0.11 | |
Diluted EPS (Cont. Ops) | $7.39 | $0.76 | $0.83 | -$0.15 | $0.11 | |
Weighted Average Basic Share | $1M | $43.2M | $51.6M | $51.3M | $53.1M | |
Weighted Average Diluted Share | $1.1M | $47.3M | $53.1M | $51.5M | $53.4M | |
EBITDA | $34.1M | $69.7M | $66.9M | $48K | $26.2M | |
EBIT | $9.8M | $56.7M | $55M | -$10.8M | $9.7M | |
Revenue (Reported) | $208.9M | $340.4M | $408.5M | $334.5M | $345.1M | |
Operating Income (Reported) | $9.8M | $56.7M | $55M | -$10.8M | $9.7M | |
Operating Income (Adjusted) | $9.8M | $56.7M | $55M | -$10.8M | $9.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $58.4M | $122.8M | $78.3M | $90.5M | $65.8M | |
Revenue Growth (YoY) | 2.28% | 110.16% | -36.27% | 15.68% | -27.35% | |
Cost of Revenues | $38.6M | $76.1M | $53.9M | $61.7M | $47.8M | |
Gross Profit | $19.8M | $46.7M | $24.4M | $28.8M | $18M | |
Gross Profit Margin | 33.94% | 38.03% | 31.16% | 31.81% | 27.31% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13.3M | $23.8M | $25.2M | $24.1M | $24.6M | |
Other Inc / (Exp) | -$130K | -$869K | -$101K | $2.1M | $1.8M | |
Operating Expenses | $6.9M | $23.8M | $25.2M | $24.1M | $24.6M | |
Operating Income | $12.9M | $22.9M | -$833K | $4.7M | -$6.6M | |
Net Interest Expenses | $258K | $195K | -- | $935K | $1.2M | |
EBT. Incl. Unusual Items | $12.5M | $21.9M | $113K | $5.9M | -$6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.5M | $4.6M | $108K | -$401K | -$720K | |
Net Income to Company | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Basic EPS (Cont. Ops) | $0.24 | $0.33 | $0.00 | $0.12 | -$0.10 | |
Diluted EPS (Cont. Ops) | $0.23 | $0.32 | $0.00 | $0.12 | -$0.10 | |
Weighted Average Basic Share | $42.2M | $51.7M | $51.2M | $53M | $52.3M | |
Weighted Average Diluted Share | $44.2M | $53.5M | $53M | $53.2M | $52.3M | |
EBITDA | $16.2M | $25.8M | $1.7M | $9.6M | $180K | |
EBIT | $12.8M | $22.9M | -$833K | $6.8M | -$4.8M | |
Revenue (Reported) | $58.4M | $122.8M | $78.3M | $90.5M | $65.8M | |
Operating Income (Reported) | $12.9M | $22.9M | -$833K | $4.7M | -$6.6M | |
Operating Income (Adjusted) | $12.8M | $22.9M | -$833K | $6.8M | -$4.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $210.2M | $404.8M | $364M | $346.8M | $320.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $152.9M | $258.5M | $234.9M | $249.9M | $227.2M | |
Gross Profit | $57.3M | $146.3M | $129.1M | $96.8M | $93.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $55.7M | $88M | $97.8M | $102.1M | $94.7M | |
Other Inc / (Exp) | $1.6M | -$8.6M | $2.5M | $5.2M | $3.5M | |
Operating Expenses | $36.7M | $79.5M | $97.8M | $102.1M | $94.7M | |
Operating Income | $20.7M | $66.7M | $31.3M | -$5.3M | -$1.6M | |
Net Interest Expenses | $1.4M | $917K | -- | $1.8M | $5.9M | |
EBT. Incl. Unusual Items | $20.9M | $57.1M | $36.1M | -$1.9M | -$4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.8M | $13.8M | $9.5M | -$2.6M | $1.7M | |
Net Income to Company | $17.1M | $43.3M | $26.6M | $709K | -$5.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $17.1M | $43.3M | $26.6M | $709K | -$5.7M | |
Basic EPS (Cont. Ops) | $183.48 | $0.92 | $0.52 | $0.02 | -$0.11 | |
Diluted EPS (Cont. Ops) | $183.47 | $0.87 | $0.48 | -$0.01 | -$0.11 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $40.5M | $78.8M | $42.8M | $7.9M | $18.9M | |
EBIT | $20.7M | $66.5M | $31.3M | -$3.1M | $265K | |
Revenue (Reported) | $210.2M | $404.8M | $364M | $346.8M | $320.3M | |
Operating Income (Reported) | $20.7M | $66.7M | $31.3M | -$5.3M | -$1.6M | |
Operating Income (Adjusted) | $20.7M | $66.5M | $31.3M | -$3.1M | $265K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $58.4M | $122.8M | $78.3M | $90.5M | $65.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $38.6M | $76.1M | $53.9M | $61.7M | $47.8M | |
Gross Profit | $19.8M | $46.7M | $24.4M | $28.8M | $18M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13.3M | $23.8M | $25.2M | $24.1M | $24.6M | |
Other Inc / (Exp) | -$130K | -$869K | -$101K | $2.1M | $1.8M | |
Operating Expenses | $6.9M | $23.8M | $25.2M | $24.1M | $24.6M | |
Operating Income | $12.9M | $22.9M | -$833K | $4.7M | -$6.6M | |
Net Interest Expenses | $258K | $195K | -- | $935K | $1.2M | |
EBT. Incl. Unusual Items | $12.5M | $21.9M | $113K | $5.9M | -$6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.5M | $4.6M | $108K | -$401K | -$720K | |
Net Income to Company | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Basic EPS (Cont. Ops) | $0.24 | $0.33 | $0.00 | $0.12 | -$0.10 | |
Diluted EPS (Cont. Ops) | $0.23 | $0.32 | $0.00 | $0.12 | -$0.10 | |
Weighted Average Basic Share | $42.2M | $51.7M | $51.2M | $53M | $52.3M | |
Weighted Average Diluted Share | $44.2M | $53.5M | $53M | $53.2M | $52.3M | |
EBITDA | $16.2M | $25.8M | $1.7M | $9.6M | $180K | |
EBIT | $12.8M | $22.9M | -$833K | $6.8M | -$4.8M | |
Revenue (Reported) | $58.4M | $122.8M | $78.3M | $90.5M | $65.8M | |
Operating Income (Reported) | $12.9M | $22.9M | -$833K | $4.7M | -$6.6M | |
Operating Income (Adjusted) | $12.8M | $22.9M | -$833K | $6.8M | -$4.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $29.3M | $130.2M | $147.2M | $5.9M | $4.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $50.2M | $29.4M | $28.3M | $31.2M | $34.6M | |
Inventory | $85.2M | $81.8M | $117.5M | $177.8M | $224.8M | |
Prepaid Expenses | $6.2M | $14.3M | $27.6M | $35.8M | $6.8M | |
Other Current Assets | $7.6M | $15.9M | $13M | $12.5M | $11.1M | |
Total Current Assets | $179M | $271.5M | $333.6M | $264.8M | $284M | |
Property Plant And Equipment | $94.7M | $80.7M | $75.6M | $81.7M | $137.3M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $19.9M | $19.9M | $19.9M | $19.9M | $19.9M | |
Other Intangibles | $28.4M | $26.2M | $24.1M | $22M | $20.5M | |
Other Long-Term Assets | $55.5M | $77.5M | $66.7M | $151.9M | $131.6M | |
Total Assets | $389.1M | $487.5M | $531.6M | $553.9M | $604.7M | |
Accounts Payable | $16.4M | $20M | $21.1M | $29.9M | $34.2M | |
Accrued Expenses | $1.8M | $1.9M | $2.7M | $3.1M | $3.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $1.3M | $605K | |
Current Portion Of Capital Lease Obligations | -- | -- | $4.4M | $4.6M | $4.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $31.7M | $67.9M | $52.8M | $45.7M | $75M | |
Long-Term Debt | -- | -- | -- | $36.3M | $40.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $37.7M | $78.6M | $86.6M | $108.9M | $149.1M | |
Common Stock | $4K | $5K | $5K | $5K | $5K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $351.5M | $408.9M | $445M | $445M | $455.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $351.5M | $408.9M | $445M | $445M | $455.6M | |
Total Liabilities and Equity | $389.1M | $487.5M | $531.6M | $553.9M | $604.7M | |
Cash and Short Terms | $29.3M | $130.2M | $147.2M | $5.9M | $4.7M | |
Total Debt | -- | -- | -- | $37.6M | $41M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $19.6M | $171.7M | $87.7M | $2.6M | $4.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $48.5M | $42.9M | $36.3M | $30.1M | $39.9M | |
Inventory | $99.3M | $80.3M | $146.4M | $203.7M | $265.6M | |
Prepaid Expenses | $10.7M | $16.2M | $29M | $37.6M | $6.7M | |
Other Current Assets | $5.6M | $3.2M | $27M | $12.8M | $10.2M | |
Total Current Assets | $183.7M | $314.3M | $326.4M | $288.4M | $329.3M | |
Property Plant And Equipment | $90.1M | $62.1M | $78M | $80M | $138.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $19.9M | $19.9M | $19.9M | -- | $19.9M | |
Other Intangibles | $27.8M | $25.7M | $23.6M | -- | $20M | |
Other Long-Term Assets | $65.9M | $68.8M | $77.3M | $147.7M | $126.2M | |
Total Assets | $400.4M | $503M | $537.3M | $571.7M | $646.1M | |
Accounts Payable | $19.2M | $20.2M | $35.1M | $26.3M | $27.5M | |
Accrued Expenses | $1.3M | $2.8M | $2.9M | $3.1M | $4.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $1M | $825K | |
Current Portion Of Capital Lease Obligations | -- | -- | $4.6M | $4.4M | $4.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $31.1M | $63.6M | $56.9M | $40.2M | $72.6M | |
Long-Term Debt | -- | -- | -- | $55.5M | $134.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $38.7M | $73M | $89.7M | $119.7M | $239.6M | |
Common Stock | $4K | $5K | $5K | $5K | $5K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $361.7M | $430M | $447.6M | $452M | $406.5M | |
Total Liabilities and Equity | $400.4M | $503M | $537.3M | $571.7M | $646.1M | |
Cash and Short Terms | $19.6M | $171.7M | $87.7M | $2.6M | $4.7M | |
Total Debt | -- | -- | -- | $56.5M | $135M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.1M | $36.1M | $43.9M | -$5.6M | $5.9M | |
Depreciation & Amoritzation | $24.2M | $13M | $11.9M | $10.8M | $16.4M | |
Stock-Based Compensation | $1M | $12.7M | $16.5M | $12.1M | $4.3M | |
Change in Accounts Receivable | $9.9M | -$3.3M | -$1M | -$4.6M | -$4M | |
Change in Inventories | -$55.3M | -$35.7M | -$37.6M | -$168.6M | -$78M | |
Cash From Operations | -$12.2M | $79.1M | -$113K | -$174.2M | $11.2M | |
Capital Expenditures | $7.3M | $3.9M | $15.6M | $11.4M | $29M | |
Cash Acquisitions | -$17M | -- | -- | -- | -- | |
Cash From Investing | -$21.1M | $13.2M | $41.4M | $3.1M | -$16.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $96.7M | -- | -- | $91.3M | $195.1M | |
Long-Term Debt Repaid | -$100.2M | -- | -- | -$53.7M | -$191.6M | |
Repurchase of Common Stock | -- | -- | -$22.2M | -- | -- | |
Other Financing Activities | $48.6M | -$694K | -$2.6M | -$8.4M | -$250K | |
Cash From Financing | $45.2M | $8.6M | -$24.3M | $29.7M | $3.8M | |
Beginning Cash (CF) | $17.5M | $29.3M | $130.2M | $147.2M | $5.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.8M | $100.9M | $17M | -$141.3M | -$1.2M | |
Ending Cash (CF) | $29.3M | $130.2M | $147.2M | $5.9M | $4.7M | |
Levered Free Cash Flow | -$19.5M | $75.2M | -$15.7M | -$185.5M | -$17.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Depreciation & Amoritzation | $3.5M | $2.9M | $2.6M | $2.8M | $5M | |
Stock-Based Compensation | -- | $3.8M | $2.7M | $799K | $1.2M | |
Change in Accounts Receivable | $1.7M | -$5.5M | -$8M | $1.2M | -$5.5M | |
Change in Inventories | -$27M | $28.2M | -$49M | -$24M | -$39.7M | |
Cash From Operations | -$14M | $43M | -$62.4M | -$21.5M | -$45.2M | |
Capital Expenditures | $443K | $1.6M | $1.5M | $3.6M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $4M | -$1.6M | $3M | $226K | -$3.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $61.6M | $149.2M | |
Long-Term Debt Repaid | -- | -- | -- | -$43.5M | -$55.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$45M | |
Other Financing Activities | -$269K | -- | -$70K | -$108K | -$159K | |
Cash From Financing | $276K | $125K | -$70K | $18M | $48.8M | |
Beginning Cash (CF) | $29.3M | $130.2M | $147.2M | $5.9M | $4.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$9.7M | $41.5M | -$59.5M | -$3.2M | -$7K | |
Ending Cash (CF) | $19.6M | $171.7M | $87.7M | $2.6M | $4.7M | |
Levered Free Cash Flow | -$14.4M | $41.4M | -$63.9M | -$25M | -$48.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $17.1M | $43.3M | $26.6M | $709K | -$5.7M | |
Depreciation & Amoritzation | $19.8M | $12.4M | $11.6M | $11.1M | $18.6M | |
Stock-Based Compensation | $1M | $16.5M | $15.5M | $10.1M | $4.7M | |
Change in Accounts Receivable | -$689K | -$10.6M | -$3.5M | $4.6M | -$10.6M | |
Change in Inventories | -$80.8M | $19.5M | -$114.8M | -$143.6M | -$93.8M | |
Cash From Operations | -$47.6M | $136.1M | -$105.6M | -$133.2M | -$12.6M | |
Capital Expenditures | $6.5M | $5.1M | $15.4M | $13.5M | $29M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $1M | $7.6M | $46M | $298K | -$19.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $152.9M | $282.6M | |
Long-Term Debt Repaid | -- | -- | -- | -$97.2M | -$203.4M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$8.4M | -$301K | |
Cash From Financing | -$13.5M | $8.4M | -$24.5M | $47.8M | $34.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$60.1M | $152.1M | -$84M | -$85.1M | $2.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$54.1M | $131M | -$121M | -$146.6M | -$41.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $10M | $17.2M | $5K | $6.3M | -$5.3M | |
Depreciation & Amoritzation | $3.5M | $2.9M | $2.6M | $2.8M | $5M | |
Stock-Based Compensation | -- | $3.8M | $2.7M | $799K | $1.2M | |
Change in Accounts Receivable | $1.7M | -$5.5M | -$8M | $1.2M | -$5.5M | |
Change in Inventories | -$27M | $28.2M | -$49M | -$24M | -$39.7M | |
Cash From Operations | -$14M | $43M | -$62.4M | -$21.5M | -$45.2M | |
Capital Expenditures | $443K | $1.6M | $1.5M | $3.6M | $3.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $4M | -$1.6M | $3M | $226K | -$3.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $61.6M | $149.2M | |
Long-Term Debt Repaid | -- | -- | -- | -$43.5M | -$55.3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$45M | |
Other Financing Activities | -$269K | -- | -$70K | -$108K | -$159K | |
Cash From Financing | $276K | $125K | -$70K | $18M | $48.8M | |
Beginning Cash (CF) | $29.3M | $130.2M | $147.2M | $5.9M | $4.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$9.7M | $41.5M | -$59.5M | -$3.2M | -$7K | |
Ending Cash (CF) | $19.6M | $171.7M | $87.7M | $2.6M | $4.7M | |
Levered Free Cash Flow | -$14.4M | $41.4M | -$63.9M | -$25M | -$48.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.